Sydney Jennings

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids

Your daily dose of clinical news you may have missed.

The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.

Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Pfizer and BioNTech submitted an application to the FDA for emergency use authorization of their omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.

Your daily dose of clinical news you may have missed.

Being most physically active in the late morning had a 16% decreased risk of coronary artery disease and a 17% decreased risk of stroke compared to midday.

Your daily dose of clinical news you may have missed.

Pandemic-related stress and depression may be slowing recovery from long COVID-19 and other illnesses, according to researchers.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

New findings suggest that the elevated risk of overdose with benzodiazepine use for sleep disorders is a critical safety consideration when treating young people.

Your daily dose of clinical news you may have missed.

Large study comparing spinal cord stimulators to conventional medical management found a lack of clinical benefit for most patients and possible harm to some.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Wearable activity trackers could potentially support clinical care for patients with pulmonary arterial hypertension, according to a new study.

Your daily dose of clinical news you may have missed.

A preliminary assessment from the FDA suggests certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.

A guideline topline of the CDC's 2022 clinical guidance for prescribing opioids for pain in adults.

Your daily dose of clinical news you may have missed.

Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.